A federal rule now under consideration would attack the problem earlier, by making cigarettes far less capable of creating dependence in the first place.
Researchers at Rutgers Health modeled what would happen if the Food and Drug Administration finalized its proposed product standard capping nicotine in combusted tobacco products. Their analysis was published in the journal Tobacco Control.
What the FDA Has Proposed
Cigarettes carry an average of 10 to 14 milligrams of nicotine. The FDA proposal would cap that at 0.7 milligrams, a level the agency describes as minimally addictive or nonaddictive.
The distinction matters clinically. Combustion and tar cause most of the physical harm from smoking, but nicotine is the agent that establishes dependence and makes quitting difficult. A cap does not make cigarettes safe. It aims to make them far less habit-forming.
What the Model Projected
Researchers at the Rutgers Institute for Nicotine and Tobacco Studies and the Rutgers School of Public Health built a simulation tracking the US population through 2100.
The model followed people from birth as they moved between states such as taking up smoking, starting to vape, doing both, or developing depression. Estimates were scaled using the Medical Expenditure Panel Survey and the National Survey on Drug Use and Health.
Under the policy, the model projected smoking rates falling below 1% for every population group by 2040. Over the longer horizon it projected 1.6 million premature deaths prevented and 8 million people prevented from developing major depression by 2100.
The economic projections were also substantial: a $298 billion increase in worker productivity and a $1.3 trillion increase in consumer spending.
These are modeled projections rather than observed results, and they assume the policy is implemented and enforced. The research team has published the underlying scenarios in a public interactive tool.
Why Depression Was the Focus
The study concentrated on adults living with major depression, a group that smokes at disproportionately higher rates than the general population.
Sarah Skolnick, a postdoctoral associate at the Rutgers Institute for Nicotine and Tobacco Studies, said the modeled policy would “directly reduce tobacco-related health disparities.” She described the relationship as running both directions, with depression increasing the likelihood of smoking and smoking in turn increasing depression.
That two-way relationship is why the projected mental health effect is so large. Cutting off nicotine dependence early removes one input into a cycle that otherwise compounds.
Why Addiction Treatment Often Skips Tobacco
For treatment providers, this is familiar territory. Tobacco use is one of the most persistent co-occurring conditions in behavioral health settings, and it is frequently the one left untreated while other conditions are addressed.
Integrated care, meaning treatment that addresses a substance use disorder and a mental health condition together rather than in sequence, is the standard recommendation for co-occurring conditions. Nicotine dependence is often excluded from that plan by default.
What This Means for Treatment Seekers
Nothing changes today. A federal product standard would take years to finalize and phase in, and the researchers noted that the outcome remains uncertain.
What is actionable now is coverage. Cessation treatment, including nicotine replacement therapy and prescription medications, is covered by many insurance plans, and quitting support can often be added to an existing treatment plan rather than pursued separately.
Verify your own benefits, since coverage varies by plan. The Rutgers team also pointed out that states do not have to wait for federal action, since sales restrictions are available to them now.
Exploring Treatment Options
If tobacco use is part of the picture for you or someone in your family, useful next steps include:
- Asking any program you contact whether it treats nicotine dependence alongside other conditions, rather than treating it as optional
- Confirming what cessation medications and counseling your insurance plan covers
- Requesting screening for depression and anxiety if tobacco use has been difficult to change
- Verifying a facility’s licensing and accreditation before committing to a program
Rehab.com’s directory lists verified treatment centers nationwide, with information on levels of care, insurance accepted, and co-occurring condition programs. Search the directory or call
800-985-8516
( 
Sponsored Helpline )
to find treatment options in your area.
